Pharmacy One Plus Inc is categorized under Wholesale Pharmaceutical Products in Chicago, IL and active since 2006.
Pharmacy One Plus Inc was established in 2006, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 4234502 by the NAICS.
If you are seeking more information, feel free to contact Jawad Rabi, Owner at the company’s single location by writing to 4753 North Kedzie Avenue, Chicago, Illinois IL 60625 or by phoning (773) 267-5050. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Pharmacy One Plus Inc |
Contact Person: | Jawad Rabi, Owner |
Address: | 4753 North Kedzie Avenue, Chicago, Illinois 60625 |
Phone Number: | (773) 267-5050 |
Annual Revenue (USD): | $5.000.000 to $9.999.999 |
Founded: | 2006 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Wholesale Pharmaceutical Products |
SIC Code: | 5122 |
NAICS Code: | 4234502 |
Share This Business: |
Pharmacy One Plus Inc was started in 2006 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 4234502. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.
Feel free to contact Jawad Rabi, Owner for inquiries that concern Pharmacy One Plus Inc by calling the company number (773) 267-5050, as your correspondence is most welcome. Additionally, the physical location of the single location of Pharmacy One Plus Inc can be found at the coordinates 41.9679,-87.70841 as well as the street address 4753 North Kedzie Avenue in Chicago, Illinois 60625.
For its online presence, you may visit Pharmacy One Plus Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.